Thomas M. Gates

697 total citations
26 papers, 516 citations indexed

About

Thomas M. Gates is a scholar working on Emergency Medicine, Virology and Epidemiology. According to data from OpenAlex, Thomas M. Gates has authored 26 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Emergency Medicine, 14 papers in Virology and 11 papers in Epidemiology. Recurrent topics in Thomas M. Gates's work include HIV Research and Treatment (14 papers), HIV-related health complications and treatments (11 papers) and HIV/AIDS Research and Interventions (9 papers). Thomas M. Gates is often cited by papers focused on HIV Research and Treatment (14 papers), HIV-related health complications and treatments (11 papers) and HIV/AIDS Research and Interventions (9 papers). Thomas M. Gates collaborates with scholars based in Australia, United States and South Korea. Thomas M. Gates's co-authors include Lucette A. Cysique, Bruce J. Brew, Kirsten Moffat, Joga Chaganti, Krista J. Siefried, Caroline Rae, Nadene Dermody, Andrew Carr, Jody Kamminga and Armin Heinecke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and AIDS.

In The Last Decade

Thomas M. Gates

25 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas M. Gates Australia	13	372	238	233	93	89	26	516
Scott L. Letendre United States	13	391 1.1×	270 1.1×	228 1.0×	130 1.4×	76 0.9×	32	656
Duanghathai Suttichom Thailand	5	390 1.0×	261 1.1×	172 0.7×	97 1.0×	92 1.0×	5	487
K. Robertson United States	12	489 1.3×	328 1.4×	283 1.2×	95 1.0×	108 1.2×	19	707
Kirsten Moffat Australia	10	282 0.8×	137 0.6×	162 0.7×	69 0.7×	71 0.8×	13	421
Jeffery R. Alger United States	9	471 1.3×	246 1.0×	316 1.4×	107 1.2×	69 0.8×	12	694
Edgar Busovaca United States	13	299 0.8×	140 0.6×	209 0.9×	75 0.8×	78 0.9×	13	473
Ned Sacktor United States	12	389 1.0×	215 0.9×	211 0.9×	66 0.7×	90 1.0×	19	554
Deborah McMahon United States	7	276 0.7×	153 0.6×	166 0.7×	79 0.8×	51 0.6×	9	389
Jennifer Marquie‐Beck United States	14	441 1.2×	269 1.1×	214 0.9×	131 1.4×	102 1.1×	18	699
Terry Alexander United States	11	278 0.7×	222 0.9×	227 1.0×	71 0.8×	30 0.3×	11	470

Countries citing papers authored by Thomas M. Gates

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Gates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Gates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Gates more than expected).

Fields of papers citing papers by Thomas M. Gates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Gates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Gates. The network helps show where Thomas M. Gates may publish in the future.

Co-authorship network of co-authors of Thomas M. Gates

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Gates. A scholar is included among the top collaborators of Thomas M. Gates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Gates. Thomas M. Gates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gates, Thomas M., et al.. (2023). Validation of the work-ability support scale in individuals seeking to return to work after severe acquired brain injury. Disability and Rehabilitation. 46(14). 3164–3175.

Chaganti, Joga, Thomas M. Gates, & Bruce J. Brew. (2023). Reversible large-scale network disruption correlates with neurocognitive improvement in HIV-associated minor neurocognitive disorder with combined anti-retroviral therapy intensification: a prospective longitudinal resting-state functional magnetic resonance imaging study. Neurological Sciences. 44(9). 3261–3269. 3 indexed citations

Simpson, Grahame, et al.. (2023). A vocational intervention that enhances return to work after severe acquired brain injury: A pragmatic trial. Annals of Physical and Rehabilitation Medicine. 66(8). 101787–101787. 3 indexed citations

Suzuki, Kazuo, John Zaunders, Thomas M. Gates, et al.. (2022). Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury. Proceedings of the National Academy of Sciences. 119(48). e2210584119–e2210584119. 18 indexed citations

Gates, Thomas M., et al.. (2022). Abnormal cognitive aging in people with HIV: evidence from data integration between two countries’ cohort studies. AIDS. 36(8). 1171–1179. 4 indexed citations

Vardy, Janette L., Gregory R. Pond, Lucette A. Cysique, et al.. (2022). Lack of cognitive impairment in long-term survivors of colorectal cancer. Supportive Care in Cancer. 30(7). 6123–6133. 11 indexed citations

Siefried, Krista J., Thomas M. Gates, Bruce J. Brew, et al.. (2022). Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not. EClinicalMedicine. 56. 101792–101792. 15 indexed citations

Gates, Thomas M., et al.. (2022). What are the predictors of TOMM failure in clinical TBI populations? A retrospective analysis. Journal of the International Neuropsychological Society. 29(4). 336–345. 2 indexed citations

Chaganti, Joga, Lukas Staub, Caroline Rae, et al.. (2019). Imaging correlates of the blood–brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications. AIDS. 33(12). 1843–1852. 36 indexed citations

10.

Kootar, Scherazad, et al.. (2019). How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?. European Geriatric Medicine. 10(2). 227–238. 13 indexed citations

11.

Gates, Thomas M., James R. Soares, Kirsten Moffat, et al.. (2018). Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection. AIDS. 33(1). 55–66. 38 indexed citations

12.

Cysique, Lucette A., Lauriane Jugé, Matthew J. Lennon, et al.. (2018). HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection. AIDS. 33(3). 433–441. 15 indexed citations

13.

Cysique, Lucette A., Lauriane Jugé, Thomas M. Gates, et al.. (2018). Covertly active and progressing neurochemical abnormalities in suppressed HIV infection. Neurology Neuroimmunology & Neuroinflammation. 5(1). e430–e430. 20 indexed citations

14.

Siefried, Krista J., Limin Mao, Stephen J. Kerr, et al.. (2017). Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression. PLoS ONE. 12(4). e0174613–e0174613. 28 indexed citations

15.

Chaganti, Joga, Armin Heinecke, Thomas M. Gates, Kirsten Moffat, & Bruce J. Brew. (2017). Functional Connectivity in Virally Suppressed Patients with HIV-Associated Neurocognitive Disorder: A Resting-State Analysis. American Journal of Neuroradiology. 38(8). 1623–1629. 41 indexed citations

16.

Gates, Thomas M., et al.. (2017). Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity. PLoS ONE. 12(3). e0171887–e0171887. 49 indexed citations

17.

Gates, Thomas M., et al.. (2017). The impact of compensation on late mortality after traumatic brain injury: A multi-centre study. Brain Injury. 31(8). 1044–1049. 2 indexed citations

18.

Gates, Thomas M., Lucette A. Cysique, Krista J. Siefried, et al.. (2016). Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder. AIDS. 30(4). 591–600. 90 indexed citations

19.

Gates, Thomas M. & Lucette A. Cysique. (2016). The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review. CNS Drugs. 30(1). 53–69. 40 indexed citations

20.

Cysique, Lucette A., Robert K. Heaton, Jody Kamminga, et al.. (2014). HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. Journal of NeuroVirology. 20(3). 258–268. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact